| Unique ID issued by UMIN | UMIN000063031 |
|---|---|
| Receipt number | R000072153 |
| Scientific Title | Effects of 4-week continuous intake of mineral-rich water on skin condition and advanced glycation end products: a randomized staggered-start intervention study |
| Date of disclosure of the study information | 2026/09/23 |
| Last modified on | 2026/09/23 18:06:33 |
Effects of 4-week continuous intake of mineral-rich water on skin condition and glycation-related indices
Mineral Water Skin and Glycation Study
Effects of 4-week continuous intake of mineral-rich water on skin condition and advanced glycation end products: a randomized staggered-start intervention study
Mineral Water Skin Aging Study
| Japan |
Age-related changes in skin condition and glycation-related indices
| Adult |
Others
NO
The purpose of this study is to examine the effects of 4 weeks of continuous intake of mineral-rich water on skin condition and glycation-related indices associated with advanced glycation end products (AGEs) in women aged 50-69 years. Each participant will complete a 4-week control period during which usual lifestyle is maintained, followed by a 4-week mineral-water intervention period. Changes during the control and intervention periods will be compared within participants. Participants will be assigned to one of two groups with study initiation staggered by 2 weeks.
Efficacy
The primary outcome is the difference between the change in the glycation-related index associated with AGEs during the 4-week control period and the change during the subsequent 4-week mineral-water intervention period. Measurements will be performed at weeks 0, 4, and 8 for each participant. Control-period change: week 4 minus week 0. Intervention-period change: week 8 minus week 4. The primary analysis will compare the changes during the control and intervention periods within participants.
Secondary outcomes include skin texture, skin brightness, skin spots, skin aging-related indices, and skin moisture. Each outcome will be assessed at weeks 0, 4, and 8. Changes during the 4-week control period and the subsequent 4-week mineral-water intervention period will be calculated and compared within participants.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
NO
NO
2
Prevention
| Food |
[Group A: Earlier-start group] Participants will maintain their usual diet, fluid intake, physical activity, and lifestyle for the first 4 weeks without consuming the study mineral water. No additional restriction or prescribed intake of ordinary drinking water will be imposed. After the 4-week control period, participants will consume the study mineral-rich water continuously for 4 weeks while maintaining their usual lifestyle. Skin condition and the glycation-related index associated with AGEs will be assessed at baseline, week 4, and week 8. Both groups undergo the identical control and intervention periods; only the study start timing differs by 2 weeks between groups. Planned start date: September 24, 2026. Planned end date: around November 19, 2026.
[Group B: Later-start group] Participants will begin the study 2 weeks after Group A. Participants will maintain their usual diet, fluid intake, physical activity, and lifestyle for the first 4 weeks without consuming the study mineral water. No additional restriction or prescribed intake of ordinary drinking water will be imposed. After the 4-week control period, participants will consume the study mineral-rich water continuously for 4 weeks while maintaining their usual lifestyle. Skin condition and the glycation-related index associated with AGEs will be assessed at baseline, week 4, and week 8. Both groups undergo the identical control and intervention periods; only the study start timing differs by 2 weeks between groups. Planned start date: October 8, 2026. Planned end date: around December 3, 2026.
| 50 | years-old | <= |
| 69 | years-old | >= |
Female
1. Women aged 50-69 years
2. Individuals who understand the study procedures and provide written informed consent
3. Individuals who are able to continuously consume the specified mineral-rich water for 4 weeks
4. Individuals who are able to participate in the scheduled assessments during the study period
5. Individuals who are able to maintain their usual lifestyle during the study period
1. Individuals with a disease, allergy, or other health condition considered incompatible with consumption of the study product
2. Individuals planning to initiate new treatment, health foods, or supplements during the study period that may substantially affect skin condition or glycation-related indices
3. Individuals who are unable to comply with the specified intake procedure or assessment schedule
4. Individuals judged by the principal investigator or co-investigators to be inappropriate for participation in the study
30
| 1st name | Shiho |
| Middle name | |
| Last name | Kurosaka |
Hiroshima University
Graduate School of Humanities and Social Sciences
739-8524
1-1-1 Kagamiyama, Higashi-Hiroshima City, Hiroshima 739-8524, Japan
082-424-6844
shihok@hiroshima-u.ac.jp
| 1st name | Shiho |
| Middle name | |
| Last name | Kurosaka |
Hiroshima University
Graduate School of Humanities and Social Sciences
739-8524
1-1-1 Kagamiyama, Higashi-Hiroshima City, Hiroshima 739-8524, Japan
082-424-6844
shihok@hiroshima-u.ac.jp
Hiroshima University
JES Co., Ltd.
Profit organization
Japan
Research Ethics Committee, Graduate School of Humanities and Social Sciences, Hiroshima University
1-1-1 Kagamiyama, Higashi-Hiroshima City, Hiroshima 739-8524, Japan
082-424-6705
shihok@hiroshima-u.ac.jp
NO
広島大学(広島県)
Hiroshima University (Hiroshima, Japan)
| 2026 | Year | 09 | Month | 23 | Day |
Unpublished
Preinitiation
| 2026 | Year | 09 | Month | 23 | Day |
| 2026 | Year | 01 | Month | 08 | Day |
| 2026 | Year | 09 | Month | 24 | Day |
| 2026 | Year | 12 | Month | 03 | Day |
This study is conducted under a collaborative research agreement between Hiroshima University and JES Co., Ltd. JES Co., Ltd. provides research funding and the mineral-rich water used as the study product but has no role in the study design, participant recruitment or allocation, conduct of the intervention, measurements, data collection or management, statistical analysis, or interpretation of the results.
| 2026 | Year | 09 | Month | 23 | Day |
| 2026 | Year | 09 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072153